Targeting Plk1 Sensitizes Pancreatic Cancer to Immune Checkpoint TherapyZhuangzhuang Zhang, Xiaoqi Liu, Anju Karki et al.|Cancer Research|2022Cited by 68
Presence of an Artificial Intelligence–powered Predictive Biomarker Is Associated with a Poor Response to Intravesical Bacillus Calmette-Guerin but Not to Intravesical Sequential Gemcitabine/Docetaxel in Patients with High-grade Non–muscle-invasive Bladder CancerVignesh T. Packiam, Patrick J. Hensley, Ian M. McElree et al.|European Urology Oncology|2025Cited by 6